Advertisement
Ligand Pharmaceuticals (LGNDV)
NASDAQ: LGNDV
· Real-Time Price · USD
50.00
0.00 (0.00%)
At close: Apr 24, 2025, 3:47 PM
0.00% (1D)
| Bid | n/a |
| Market Cap | 0 |
| Revenue (ttm) | n/a |
| Net Income (ttm) | n/a |
| EPS (ttm) | n/a |
| PE Ratio (ttm) | n/a |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | n/a |
| Volume | 215 |
| Avg. Volume (20D) | 0 |
| Open | 50.00 |
| Previous Close | 50.00 |
| Day's Range | 50.00 - 50.00 |
| 52-Week Range | 50.00 - 50.00 |
| Beta | 1.07 |
About LGNDV
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19; Teriparatide injection product for osteoporosis; Vaxneuvance for the prevention of invasive disease ca...
Industry Biotechnology
Sector Healthcare
IPO Date Oct 26, 2022
Employees 154
Stock Exchange NASDAQ
Ticker Symbol LGNDV
Website https://www.ligand.com